These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 24260121

  • 1. Human factor H-related protein 2 (CFHR2) regulates complement activation.
    Eberhardt HU, Buhlmann D, Hortschansky P, Chen Q, Böhm S, Kemper MJ, Wallich R, Hartmann A, Hallström T, Zipfel PF, Skerka C.
    PLoS One; 2013; 8(11):e78617. PubMed ID: 24260121
    [Abstract] [Full Text] [Related]

  • 2. Binding of the human complement regulators CFHR1 and factor H by streptococcal collagen-like protein 1 (Scl1) via their conserved C termini allows control of the complement cascade at multiple levels.
    Reuter M, Caswell CC, Lukomski S, Zipfel PF.
    J Biol Chem; 2010 Dec 03; 285(49):38473-85. PubMed ID: 20855886
    [Abstract] [Full Text] [Related]

  • 3. Factor H-related protein 4 activates complement by serving as a platform for the assembly of alternative pathway C3 convertase via its interaction with C3b protein.
    Hebecker M, Józsi M.
    J Biol Chem; 2012 Jun 01; 287(23):19528-36. PubMed ID: 22518841
    [Abstract] [Full Text] [Related]

  • 4. Complement factor H-related hybrid protein deregulates complement in dense deposit disease.
    Chen Q, Wiesener M, Eberhardt HU, Hartmann A, Uzonyi B, Kirschfink M, Amann K, Buettner M, Goodship T, Hugo C, Skerka C, Zipfel PF.
    J Clin Invest; 2014 Jan 01; 124(1):145-55. PubMed ID: 24334459
    [Abstract] [Full Text] [Related]

  • 5. A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy.
    Togarsimalemath SK, Sethi SK, Duggal R, Le Quintrec M, Jha P, Daniel R, Gonnet F, Bansal S, Roumenina LT, Fremeaux-Bacchi V, Kher V, Dragon-Durey MA.
    Kidney Int; 2017 Oct 01; 92(4):876-887. PubMed ID: 28729035
    [Abstract] [Full Text] [Related]

  • 6. Complement factor H related proteins (CFHRs).
    Skerka C, Chen Q, Fremeaux-Bacchi V, Roumenina LT.
    Mol Immunol; 2013 Dec 15; 56(3):170-80. PubMed ID: 23830046
    [Abstract] [Full Text] [Related]

  • 7. Preferential inactivation of the C5 convertase of the alternative complement pathway by factor I and membrane cofactor protein (MCP).
    Seya T, Okada M, Matsumoto M, Hong KS, Kinoshita T, Atkinson JP.
    Mol Immunol; 1991 Oct 15; 28(10):1137-47. PubMed ID: 1833639
    [Abstract] [Full Text] [Related]

  • 8. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
    Sahu A, Isaacs SN, Soulika AM, Lambris JD.
    J Immunol; 1998 Jun 01; 160(11):5596-604. PubMed ID: 9605165
    [Abstract] [Full Text] [Related]

  • 9. Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein.
    McRae JL, Duthy TG, Griggs KM, Ormsby RJ, Cowan PJ, Cromer BA, McKinstry WJ, Parker MW, Murphy BF, Gordon DL.
    J Immunol; 2005 May 15; 174(10):6250-6. PubMed ID: 15879123
    [Abstract] [Full Text] [Related]

  • 10. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.
    Moore I, Strain L, Pappworth I, Kavanagh D, Barlow PN, Herbert AP, Schmidt CQ, Staniforth SJ, Holmes LV, Ward R, Morgan L, Goodship TH, Marchbank KJ.
    Blood; 2010 Jan 14; 115(2):379-87. PubMed ID: 19861685
    [Abstract] [Full Text] [Related]

  • 11. The MFHR1 Fusion Protein Is a Novel Synthetic Multitarget Complement Inhibitor with Therapeutic Potential.
    Michelfelder S, Fischer F, Wäldin A, Hörle KV, Pohl M, Parsons J, Reski R, Decker EL, Zipfel PF, Skerka C, Häffner K.
    J Am Soc Nephrol; 2018 Apr 14; 29(4):1141-1153. PubMed ID: 29335241
    [Abstract] [Full Text] [Related]

  • 12. Common haplotypes at the CFH locus and low-frequency variants in CFHR2 and CFHR5 associate with systemic FHR concentrations and age-related macular degeneration.
    Lorés-Motta L, van Beek AE, Willems E, Zandstra J, van Mierlo G, Einhaus A, Mary JL, Stucki C, Bakker B, Hoyng CB, Fauser S, Clark SJ, de Jonge MI, Nogoceke E, Koertvely E, Jongerius I, Kuijpers TW, den Hollander AI.
    Am J Hum Genet; 2021 Aug 05; 108(8):1367-1384. PubMed ID: 34260947
    [Abstract] [Full Text] [Related]

  • 13. The alternative pathway of complement.
    Pangburn MK, Müller-Eberhard HJ.
    Springer Semin Immunopathol; 1984 Aug 05; 7(2-3):163-92. PubMed ID: 6238433
    [No Abstract] [Full Text] [Related]

  • 14. Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.
    Rooijakkers SH, Wu J, Ruyken M, van Domselaar R, Planken KL, Tzekou A, Ricklin D, Lambris JD, Janssen BJ, van Strijp JA, Gros P.
    Nat Immunol; 2009 Jul 05; 10(7):721-7. PubMed ID: 19503103
    [Abstract] [Full Text] [Related]

  • 15. Structure/function of C5 convertases of complement.
    Rawal N, Pangburn MK.
    Int Immunopharmacol; 2001 Mar 05; 1(3):415-22. PubMed ID: 11367526
    [Abstract] [Full Text] [Related]

  • 16. CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b.
    Blom AM, Kask L, Dahlbäck B.
    Mol Immunol; 2003 Jan 05; 39(10):547-56. PubMed ID: 12431388
    [Abstract] [Full Text] [Related]

  • 17. Decay acceleration of the complement alternative pathway C3 convertase.
    Hourcade DE, Mitchell LM, Medof ME.
    Immunopharmacology; 1999 May 05; 42(1-3):167-73. PubMed ID: 10408377
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein.
    Hong K, Kinoshita T, Takeda J, Kozono H, Pramoonjago P, Kim YU, Inoue K.
    Infect Immun; 1990 Aug 05; 58(8):2535-41. PubMed ID: 2142480
    [Abstract] [Full Text] [Related]

  • 19. The separation of functionally distinct forms of the third component of human complement (C3).
    Parkes C, DiScipio RG, Kerr MA, Prohaska R.
    Biochem J; 1981 Mar 01; 193(3):963-70. PubMed ID: 6458280
    [Abstract] [Full Text] [Related]

  • 20. Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy.
    Márquez-Tirado B, Gutiérrez-Tenorio J, Tortajada A, Lucientes Continente L, Caravaca-Fontán F, Malik TH, Roldán Montero R, Elías S, Saiz Gonzalez A, Fernández-Juarez G, Sánchez-Corral P, Pickering MC, Praga M, Rodríguez de Córdoba S, Goicoechea de Jorge E.
    J Am Soc Nephrol; 2022 Jun 01; 33(6):1137-1153. PubMed ID: 35545301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.